Question

Is stem cell therapy for Parkinson's Disease covered by insurance?

Coverage varies and investigational products are commonly handled through sponsor-specific arrangements rather than ordinary treatment benefits. Obtain written statements on research costs, routine care, surgery, travel and injury or complication coverage.

Medical review statusPending clinical sign-offLast evidence update: 2026-08-05Methodology and editorial standards
Clinical review team: Dr Kamelia Milcheva, Hematologist · Dr Vadym Uvarov, Board-Certified Physician · Hepatobiliary Surgeon · Candidate of Medical SciencesEditorial responsibility: StemCellAtlas research teamEducational information only. This page does not provide medical advice, diagnosis or a treatment recommendation.

The cost picture for Parkinson's Disease

A same-day intravenous product cannot be priced or evaluated as equivalent to a neurosurgical cell-replacement trial. Request an itemised statement for product, surgery or administration, imaging, immunosuppression where applicable, monitoring, travel and long-term follow-up. Preserve access to established neurological care.

Am I a candidate? → · Parkinson's Disease: full overview → · Parkinson's Disease cost → · Cost →

Evidence checked against ISSCR, FDA and EMA guidance. See our editorial standards. This is information, not medical advice. Educational information, not medical advice; figures indicative.

Sources & further reading

Explore all sections · Data & downloads

Compare cell-therapy evidence, registered studies and published price observations.

StemCellAtlas is a source-first research and cost-planning guide. It separates registry and regulator evidence from heterogeneous commercial observations.

Request written information